Alyssum Therapeutics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
626 Massachusetts Ave Fl 2, Cambridge, M...Website
www.alyssumtx.comRevenue
<$5 MillionIndustry
About Alyssum Therapeutics
Alyssum Therapeutics is focused on developing innovative drugs that transform the treatment of complex diseases, particularly through targeted immunotherapy. The company specializes in modulating B cells, which play a crucial role in immunity and have shown potential in improving survival outcomes in various tumors. Their lead molecule, AT1965, is currently in clinical trials for treating solid cancers, utilizing a unique mechanism that combines targeted therapy with immune response modulation. With a strong pipeline and a patented platform, Alyssum aims to enhance the efficacy and safety of its therapeutic offerings.Explore more
SIC Code 28,283NAICS Code 32,325Show moreAlyssum Therapeutics Org Chart
Compare Similar Companies to Alyssum Therapeutics
Compare insights from companies similar to Alyssum Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Alyssum Therapeutics Tech Stack
A closer look at the technologies used by Alyssum Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Alyssum Therapeutics
Sign Up For FreeTo access detailed company insights
Alyssum Therapeutics is focused on developing innovative drugs that transform the treatment of complex diseases, particularly through targeted immunotherapy. The company specializes in modulating B cells, which play a crucial role in immunity and have shown potential in improving survival outcomes in various tumors. Their lead molecule, AT1965, is... Read More
